Orbital Lymphoma — Trials

Orbital Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: British Columbia Cancer Agency
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02494700	Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mantle Cell Lymphoma	active not recruiting	Phase 2	50	M.D. Anderson Cancer CenterOTHER	1	Jul 15, 2026	clinicaltrials
NCT07210749	Radiotherapy 12Gy in 6 Fractions For Orbital Lymphoma	not yet recruiting	N/A	36	British Columbia Cancer AgencyOTHER	1	Oct 7, 2025	clinicaltrials